• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向前之路:通过记忆 CD4 T 细胞的参与增强对新型和大流行性流感的保护性免疫。

The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells.

机构信息

David H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, New York.

出版信息

J Infect Dis. 2019 Apr 8;219(Suppl_1):S30-S37. doi: 10.1093/infdis/jiy666.

DOI:10.1093/infdis/jiy666
PMID:30715376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6452298/
Abstract

Potentially pandemic strains of influenza pose an undeniable threat to human populations. Therefore, it is essential to develop better strategies to enhance vaccine design and predict parameters that identify susceptible humans. CD4 T cells are a central component of protective immunity to influenza, delivering direct effector function and potentiating responses of other lymphoid cells. Humans have highly diverse influenza-specific CD4 T-cell populations that vary in stimulation history, specificity, and functionality. These complexities constitute a formidable obstacle to predicting immune responses to pandemic strains of influenza and derivation of optimal vaccine strategies. We suggest that more precise efforts to identify and enumerate both the positive and negative contributors of immunity in the CD4 T-cell compartment will aid in both predicting susceptible hosts and in development of vaccination strategies that will poise most human subjects to respond to pandemic influenza strains with protective immune responses.

摘要

具有大流行潜力的流感株对人类构成了不可否认的威胁。因此,开发更好的策略来增强疫苗设计和预测识别易感人群的参数至关重要。CD4 T 细胞是流感保护性免疫的核心组成部分,发挥直接效应功能,并增强其他淋巴细胞的反应。人类具有高度多样化的流感特异性 CD4 T 细胞群体,其刺激史、特异性和功能各不相同。这些复杂性构成了预测对大流行流感株的免疫反应和制定最佳疫苗策略的巨大障碍。我们认为,更精确地努力识别和列举 CD4 T 细胞区室中免疫的正负贡献者,将有助于预测易感宿主,并开发使大多数人类宿主能够对大流行流感株产生保护性免疫反应的疫苗接种策略。

相似文献

1
The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells.向前之路:通过记忆 CD4 T 细胞的参与增强对新型和大流行性流感的保护性免疫。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S30-S37. doi: 10.1093/infdis/jiy666.
2
How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.减毒活疫苗如何为广泛交叉保护性流感疫苗的研发提供信息。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S81-S87. doi: 10.1093/infdis/jiy703.
3
Antibody Determinants of Influenza Immunity.流感免疫的抗体决定簇。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S21-S29. doi: 10.1093/infdis/jiz010.
4
A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.通过季节性流感建立的记忆 CD4 T 细胞动员克服禽流感疫苗免疫原性差的新型疫苗策略。
J Immunol. 2019 Sep 15;203(6):1502-1508. doi: 10.4049/jimmunol.1900819. Epub 2019 Aug 9.
5
Influenza vaccination strategies targeting the hemagglutinin stem region.针对血凝素茎区域的流感疫苗接种策略。
Immunol Rev. 2020 Jul;296(1):132-141. doi: 10.1111/imr.12887. Epub 2020 Jun 16.
6
Protein Vaccination Directs the CD4 T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.蛋白疫苗接种使 CD4 T 细胞应答偏向于共享的保护性表位,这些表位在流感病毒感染后可以被回忆起来。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00947-19. Print 2019 Oct 15.
7
Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.AS03 佐剂季节性流感 H1N1 疫苗接种后,预先存在的免疫对功能性交叉反应性抗血凝素茎抗体诱导的影响。
Vaccine. 2018 Apr 12;36(16):2213-2219. doi: 10.1016/j.vaccine.2018.02.022. Epub 2018 Mar 13.
8
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.神经氨酸酶,被遗忘的表面抗原,作为流感疫苗靶点出现,以实现更广泛的保护。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S75-S80. doi: 10.1093/infdis/jiz017.
9
The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza.CD4 T细胞记忆在产生针对新型及潜在大流行性流感毒株的保护性免疫中的作用
Front Immunol. 2016 Jan 25;7:10. doi: 10.3389/fimmu.2016.00010. eCollection 2016.
10
Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.从 2009 年 H1N1 大流行中吸取教训:开发更广泛有效的流感疫苗的前景。
J Mol Cell Biol. 2011 Jun;3(3):144-6. doi: 10.1093/jmcb/mjq046. Epub 2011 Mar 23.

引用本文的文献

1
Airway-resident memory CD4 T cell activation accelerates antigen presentation and T cell priming in draining lymph nodes.气道驻留记忆性CD4 T细胞的激活加速了引流淋巴结中的抗原呈递和T细胞启动。
JCI Insight. 2024 Dec 17;10(3):e182615. doi: 10.1172/jci.insight.182615.
2
Influenza B: Prospects for the Development of Cross-Protective Vaccines.乙型流感:开发交叉保护疫苗的前景。
Viruses. 2022 Jun 17;14(6):1323. doi: 10.3390/v14061323.
3
The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations.高危人群对流感疫苗免疫反应的本质。

本文引用的文献

1
Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials.创新方法追踪淋巴结生发中心对人类 HIV 疫苗试验中广泛中和抗体发展的反应。
Vaccine. 2018 Sep 11;36(38):5671-5677. doi: 10.1016/j.vaccine.2018.07.071. Epub 2018 Aug 7.
2
Niches for the Long-Term Maintenance of Tissue-Resident Memory T Cells.组织驻留记忆 T 细胞的长期维持龛位。
Front Immunol. 2018 May 31;9:1214. doi: 10.3389/fimmu.2018.01214. eCollection 2018.
3
Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B Virus-Specific CD4+ T-Cell Repertoire.
Viruses. 2021 Jun 9;13(6):1109. doi: 10.3390/v13061109.
4
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.CCR2 调节疫苗诱导的流感病毒黏膜 T 细胞记忆。
J Virol. 2021 Jul 12;95(15):e0053021. doi: 10.1128/JVI.00530-21.
5
Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants.联合佐剂对多方面肺T细胞免疫的编程作用
Cell Rep Med. 2020 Sep 22;1(6):100095. doi: 10.1016/j.xcrm.2020.100095.
6
Next-generation influenza vaccines: opportunities and challenges.下一代流感疫苗:机遇与挑战。
Nat Rev Drug Discov. 2020 Apr;19(4):239-252. doi: 10.1038/s41573-019-0056-x. Epub 2020 Feb 14.
7
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.为下一次流感大流行做准备:通用流感疫苗的研发。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S107-S109. doi: 10.1093/infdis/jiz043.
循环的人甲型和乙型流感病毒特异性 CD4+ T 细胞库中存在优势免疫模式和特异性与功能的实质性多样性。
J Infect Dis. 2018 Aug 24;218(7):1169-1174. doi: 10.1093/infdis/jiy288.
4
Diverse Epitope Specificity, Immunodominance Hierarchy, and Functional Avidity of Effector CD4 T Cells Established During Priming Is Maintained in Lung After Influenza A Virus Infection.在流感病毒感染后,在肺部中维持了在初始感染时建立的效应性 CD4 T 细胞的多样化表位特异性、免疫优势等级和功能亲和力。
Front Immunol. 2018 Apr 6;9:655. doi: 10.3389/fimmu.2018.00655. eCollection 2018.
5
Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.开发基于下一代血凝素的具有广泛保护作用的流感病毒疫苗。
Curr Opin Immunol. 2018 Aug;53:51-57. doi: 10.1016/j.coi.2018.04.001. Epub 2018 Apr 20.
6
CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection.细胞从流感病毒感染后的肺部血管转移到肺部组织时,其 CD4 T 细胞表位特异性和细胞因子潜能得以保留。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00377-18. Print 2018 Jul 1.
7
Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus.CD4 效应因子对病原体的识别驱动针对呼吸道病毒的关键效应和大多数记忆细胞的产生。
Front Immunol. 2018 Mar 26;9:596. doi: 10.3389/fimmu.2018.00596. eCollection 2018.
8
Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus.CD4 T 细胞在流感病毒保护性免疫中的独特和互补作用。
Curr Opin Immunol. 2018 Aug;53:13-21. doi: 10.1016/j.coi.2018.03.019. Epub 2018 Apr 2.
9
Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine.利用T细胞的力量:通用流感疫苗的光明前景。
Vaccines (Basel). 2018 Mar 26;6(2):18. doi: 10.3390/vaccines6020018.
10
Towards a universal influenza vaccine: different approaches for one goal.迈向通用流感疫苗:殊途同归。
Virol J. 2018 Jan 19;15(1):17. doi: 10.1186/s12985-017-0918-y.